Urology最新文献

英文中文

Large Retroperitoneal Cystic Mass in a 45-Year-Old Man 一名 45 岁男子的腹膜后巨大囊性肿块

IF 2.1 3区医学 Q2 UROLOGY & NEPHROLOGY

Urology

Pub Date : 2024-11-01 DOI: 10.1016/j.urology.2024.08.036

Seoho Lee, Sean A. Fletcher, Nirmish Singla

引用次数: 0

Reply to Editorial Comment on “Association of Crowd-Sourced Assessment of Technical Skills and Outcomes of Robotic-assisted Radical Prostatectomy” 对 "众包技术技能评估 (CSATSTM) 与机器人辅助根治性前列腺切除术结果的关联 "编辑评论的回复。

IF 2.1 3区医学 Q2 UROLOGY & NEPHROLOGY

Urology

Pub Date : 2024-11-01 DOI: 10.1016/j.urology.2024.08.054

Maximilian J. Rabil , Michael S. Leapman , Jaime A. Cavallo

引用次数: 0

Telescoping the Dorsal Hood in Hypospadias Surgery: An Innovation to Preserve Maximal Penile Skin 尿道下裂手术中的阴茎背罩伸缩--一种保留最大阴茎皮肤的创新方法。

IF 2.1 3区医学 Q2 UROLOGY & NEPHROLOGY

Urology

Pub Date : 2024-11-01 DOI: 10.1016/j.urology.2024.08.015

Devesh Misra , Mohamad E. Abdullah

Objective

To describe a new technique or adjunct—telescoping the dorsal hood—with a view to banking excess skin on the penile shaft in hypospadias surgery. This would help if redo surgery, not a rare occurrence, is required in the future.

Method

A review of a prospectively maintained database of hypospadias surgeries conducted between 1997 and 2023 by a single surgeon.

After the hypospadias repair, instead of excising the dorsal hood and suturing the ventral penile skin in the usual way, a skin hook is applied on the ventral penile skin in the midline. As the skin hook is pulled down towards the scrotum, anywhere from 1 to 4 cm, it telescopes the dorsal hood down the penile shaft and also pulls in dorsal skin ventrally. (Technique described more fully in the manuscript)

Results

Around 1084 patients were operated for hypospadias over these 27 years. Telescoping of the dorsal hood was used in all patients, and in the 126 with proximal hypospadias, none had any skin of the dorsal hood excised!

Sixty-two patients presented later with 73 fistulae which were operated on. Of note, no patient needed more than 2 surgical attempts for a cure.

Conclusion

The dorsal hood is a useful source of not only skin but also underlying vascularised soft tissue. In hypospadias surgery where redo-operations are a predictable reality, preserving any excess skin on the phallus seems sensible. Our innovation of telescoping the dorsal hood achieves this goal nicely and takes only a few minutes to perform.

目的：描述一种新的技术或辅助方法--伸缩阴茎背套，以便在尿道下裂手术中保留阴茎轴上多余的皮肤。方法：回顾尿道下裂手术的前瞻性数据库：方法：对尿道下裂手术的前瞻性数据库进行回顾，该数据库由一名外科医生在 1997 年至 2023 年期间进行。尿道下裂修补术后，不是按照常规方法切除阴茎背侧皮肤罩并缝合阴茎腹侧皮肤，而是在中线的阴茎腹侧皮肤上使用皮钩。当皮钩向阴囊方向拉下 1 到 4 厘米时，会将阴茎背侧罩向下伸缩，同时将阴茎背侧皮肤向腹侧拉入。(结果：27 年间，1084 名尿道下裂患者接受了手术。所有患者都采用了背侧皮瓣扩张术，在 126 名尿道下裂近端患者中，没有一人切除背侧皮瓣！62名患者后来出现了73处瘘管，并接受了手术治疗。值得注意的是，没有一名患者需要进行两次以上的手术才能治愈：结论：背罩不仅是皮肤的有效来源，也是下层血管软组织的有效来源。在尿道下裂手术中，再次手术是可以预见的现实，因此保留阴茎上多余的皮肤似乎是明智的。我们的创新技术--伸缩阴茎背侧罩很好地实现了这一目标，而且只需几分钟即可完成。

{"title":"Telescoping the Dorsal Hood in Hypospadias Surgery: An Innovation to Preserve Maximal Penile Skin","authors":"Devesh Misra , Mohamad E. Abdullah","doi":"10.1016/j.urology.2024.08.015","DOIUrl":"10.1016/j.urology.2024.08.015","url":null,"abstract":"<div><h3>Objective</h3><div>To describe a new technique or adjunct—telescoping the dorsal hood—with a view to banking excess skin on the penile shaft in hypospadias surgery. This would help if redo surgery, not a rare occurrence, is required in the future.</div></div><div><h3>Method</h3><div>A review of a prospectively maintained database of hypospadias surgeries conducted between 1997 and 2023 by a single surgeon.</div><div>After the hypospadias repair, instead of excising the dorsal hood and suturing the ventral penile skin in the usual way, a skin hook is applied on the ventral penile skin in the midline. As the skin hook is pulled down towards the scrotum, anywhere from 1 to 4cm, it telescopes the dorsal hood down the penile shaft and also pulls in dorsal skin ventrally. (Technique described more fully in the manuscript)</div></div><div><h3>Results</h3><div>Around 1084 patients were operated for hypospadias over these 27 years. Telescoping of the dorsal hood was used in all patients, and in the 126 with proximal hypospadias, none had any skin of the dorsal hood excised!</div><div>Sixty-two patients presented later with 73 fistulae which were operated on. Of note, no patient needed more than 2 surgical attempts for a cure.</div></div><div><h3>Conclusion</h3><div>The dorsal hood is a useful source of not only skin but also underlying vascularised soft tissue. In hypospadias surgery where redo-operations are a predictable reality, preserving any excess skin on the phallus seems sensible. Our innovation of telescoping the dorsal hood achieves this goal nicely and takes only a few minutes to perform.</div></div>","PeriodicalId":23415,"journal":{"name":"Urology","volume":"193 ","pages":"Pages 182-185"},"PeriodicalIF":2.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141996628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Chromophobe Renal Cell Carcinoma in a Pediatric Patient With Neurofibromatosis Type 1: A Case Report and Review of the Literature 一名神经纤维瘤病 1 型儿科患者的肾细胞癌：病例报告和文献综述。

IF 2.1 3区医学 Q2 UROLOGY & NEPHROLOGY

Urology

Pub Date : 2024-11-01 DOI: 10.1016/j.urology.2024.08.025

Andrew Allen , Kara McAbee , John V. Kryger

Renal Cell Carcinoma is rare in the pediatric population, making up only 2%-6% of all pediatric renal tumors. Literature on pediatric Chromophobe Renal Cell Carcinoma (chRCC) is exceptionally limited. In this report, we describe the case of a 12-year-old patient with Neurofibromatosis Type 1 (NF1), incidentally found to have a kidney lesion with pathology revealing chRCC. Treatment included open partial nephrectomy with lymph node dissection and current follow-up is nearly 1 year. To our knowledge, this is the first case of chRCC in the setting of NF1.

肾细胞癌在儿科人群中非常罕见，仅占所有儿科肾肿瘤的 2-6%。有关小儿染色体异常性肾细胞癌（chRCC）的文献非常有限。在本报告中，我们描述了一名12岁神经纤维瘤病1型（NF1）患者的病例，患者偶然发现肾脏病变，病理显示为chRCC。治疗包括开放性肾部分切除术和淋巴结清扫术，目前随访近一年。据我们所知，这是第一例因患 NF1 而导致的 chRCC。

引用次数: 0

Editorial Comment on "Variation in Urology Care After Urinary Stone Surgery Among Veterans at High-risk for Recurrence". 关于 "高复发风险退伍军人尿路结石手术后泌尿科护理的差异 "的社论评论。

IF 2.1 3区医学 Q2 UROLOGY & NEPHROLOGY

Urology

Pub Date : 2024-11-01 DOI: 10.1016/j.urology.2024.10.065

Fuad Elkhoury

引用次数: 0

Editorial Comment on “Does Ta Low-grade Urothelial Carcinoma of the Bladder With Focal High-grade Features Carry Worse Prognosis? The Roswell Park Comprehensive Cancer Center Experience” 关于 "Ta 低分化膀胱尿路上皮癌伴有灶性高级别特征是否预后更差？罗斯威尔帕克综合癌症中心的经验"。

IF 2.1 3区医学 Q2 UROLOGY & NEPHROLOGY

Urology

Pub Date : 2024-11-01 DOI: 10.1016/j.urology.2024.07.019

Jennifer B. Gordetsky , Aida Valencia

引用次数: 0

The Use of Genetic Testing in Nephrolithiasis Evaluation: A Retrospective Review From a Multidisciplinary Kidney Stone Clinic 基因检测在肾结石评估中的应用：来自一家多学科肾结石诊所的回顾性研究。

IF 2.1 3区医学 Q2 UROLOGY & NEPHROLOGY

Urology

Pub Date : 2024-11-01 DOI: 10.1016/j.urology.2024.07.029

Nicolette G. Payne , Sayi P. Boddu , Kevin M. Wymer , Daniel J. Heidenberg , Charles Van Der Walt , Lanyu Mi , Mira Keddis , Karen L. Stern

Objective

To describe genetic and clinical characteristics for patients undergoing genetic testing at our multidisciplinary kidney stone clinic.

Methods

A retrospective review was performed on patients evaluated in our stone clinic and referred to genetics between 2018 and 2022. Patient demographic, clinical, stone, and genetic data were included. We assessed the specific variants identified in our cohort, both those with a pathogenic association and variants of unknown significance.

Results

Of 825 patients seen in our stone clinic from 2018-2022, 50 patients were referred to genetics. Among these patients, 33/50 (66%) underwent genetic testing and were included in the analysis. Of those who underwent genetic testing, a variant was identified in 19/33 (58%) patients, and 9/33 (27%) of these were a known pathogenic variant. Among patients with a pathogenic variant identified, the majority had a family history of stones (55.6%), calcium-based stones (77.8%), had their first stone prior to age 18 (66.7%), were recurrent stone formers (100%), and had been managed medically (88.9%) or surgically (88.9%) prior to testing. When comparing patients with a pathogenic variant, variants of unknown significance, and no variant, there were no significant differences in demographic or clinical parameters.

Conclusion

In our stone practice, more than half of patients who underwent genetic testing were found to have a variant. However, the majority of these variants were of unknown significance. Further evaluation regarding how genetic testing can impact nephrolithiasis management is needed.

目的：描述在我们的多学科肾结石诊所接受基因检测的患者的遗传和临床特征：描述在我们的多学科肾结石诊所接受基因检测的患者的遗传和临床特征：对 2018 年至 2022 年期间在我院结石门诊接受评估并转诊至遗传学的患者进行回顾性分析。研究纳入了患者的人口统计学、临床、结石和遗传学数据。我们评估了队列中发现的特定变异，包括与致病相关的变异和意义不明的变异（VUS）：2018-2022年，在我们结石门诊就诊的825名患者中，有50名患者被转诊至遗传学。在这些患者中，33/50（66%）接受了基因检测并纳入分析。在接受基因检测的患者中，19/33（58%）名患者被鉴定出变异体，其中9/33（27%）名患者为已知致病变异体。在确定了致病变异体的患者中，大多数人有结石家族史（55.6%）、钙基结石（77.8%）、18 岁前首次结石（66.7%）、反复结石（100%），并且在检测前已接受药物治疗（88.9%）或手术治疗（88.9%）。在对有致病变异、VUS和无变异的患者进行比较时，人口统计学和临床参数没有显著差异：结论：在我们的结石病诊疗中，一半以上接受基因检测的患者被发现存在变异。结论：在我们的结石诊疗过程中，半数以上接受基因检测的患者被发现存在变异，但其中大多数变异的意义不明。我们需要进一步评估基因检测对肾结石治疗的影响。

{"title":"The Use of Genetic Testing in Nephrolithiasis Evaluation: A Retrospective Review From a Multidisciplinary Kidney Stone Clinic","authors":"Nicolette G. Payne , Sayi P. Boddu , Kevin M. Wymer , Daniel J. Heidenberg , Charles Van Der Walt , Lanyu Mi , Mira Keddis , Karen L. Stern","doi":"10.1016/j.urology.2024.07.029","DOIUrl":"10.1016/j.urology.2024.07.029","url":null,"abstract":"<div><h3>Objective</h3><div>To describe genetic and clinical characteristics for patients undergoing genetic testing at our multidisciplinary kidney stone clinic.</div></div><div><h3>Methods</h3><div>A retrospective review was performed on patients evaluated in our stone clinic and referred to genetics between 2018 and 2022. Patient demographic, clinical, stone, and genetic data were included. We assessed the specific variants identified in our cohort, both those with a pathogenic association and variants of unknown significance.</div></div><div><h3>Results</h3><div>Of 825 patients seen in our stone clinic from 2018-2022, 50 patients were referred to genetics. Among these patients, 33/50 (66%) underwent genetic testing and were included in the analysis. Of those who underwent genetic testing, a variant was identified in 19/33 (58%) patients, and 9/33 (27%) of these were a known pathogenic variant. Among patients with a pathogenic variant identified, the majority had a family history of stones (55.6%), calcium-based stones (77.8%), had their first stone prior to age 18 (66.7%), were recurrent stone formers (100%), and had been managed medically (88.9%) or surgically (88.9%) prior to testing. When comparing patients with a pathogenic variant, variants of unknown significance, and no variant, there were no significant differences in demographic or clinical parameters.</div></div><div><h3>Conclusion</h3><div>In our stone practice, more than half of patients who underwent genetic testing were found to have a variant. However, the majority of these variants were of unknown significance. Further evaluation regarding how genetic testing can impact nephrolithiasis management is needed.</div></div>","PeriodicalId":23415,"journal":{"name":"Urology","volume":"193 ","pages":"Pages 20-26"},"PeriodicalIF":2.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141761224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Editorial Comment on “Ventral Onlay Buccal Mucosa Graft Urethroplasty for Female Urethral Stricture: Medium-term Results in Single Surgeon Experience” 关于 "女性尿道狭窄的腹侧嵌体颊粘膜移植尿道成形术：单个外科医生经验的中期结果。

IF 2.1 3区医学 Q2 UROLOGY & NEPHROLOGY

Urology

Pub Date : 2024-11-01 DOI: 10.1016/j.urology.2024.07.054

Jacqueline Zillioux

引用次数: 0

Letter to the Editor on “A Single Injection of Platelet-rich Plasma Injection for the Treatment of Stress Urinary Incontinence in Females: A Randomized Placebo-controlled Trial” 致编辑的信，主题为 "单次注射富血小板血浆治疗女性压力性尿失禁：随机安慰剂对照试验。

IF 2.1 3区医学 Q2 UROLOGY & NEPHROLOGY

Urology

Pub Date : 2024-11-01 DOI: 10.1016/j.urology.2024.07.056

Vivek Rathod, Kirti Singh, Sambit Tripathy, Swarnendu Mandal, Manoj Kumar Das, Prasant Nayak

引用次数: 0

Reply to Editorial Comment on “Natural History of Artificial Urinary Sphincter Erosion: Long-term Lower Urinary Tract Outcomes and Incontinence Management” 人工尿道括约肌侵蚀的自然史：人工尿道括约肌侵蚀的自然史：下尿路的长期疗效和尿失禁处理。

IF 2.1 3区医学 Q2 UROLOGY & NEPHROLOGY

Urology

Pub Date : 2024-11-01 DOI: 10.1016/j.urology.2024.08.030

Bridget L. Findlay, Anthony Fadel, Sierra T. Pence, Cameron J. Britton, Brian J. Linder, Daniel S. Elliott

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Urology

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀